SCHEMBL458306

SCHEMBL458306

O=S(=S)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL867626 0.83
Water SCHEMBL27918096 0.77
SCHEMBL31517221 0.77
Ethylene SCHEMBL28096878 0.72
SCHEMBL16660783 0.72
SCHEMBL12999335 0.72
SCHEMBL14780899 0.72
SCHEMBL10387277 0.68
Sulfurous Acid SCHEMBL7263130 0.68
Benzene SCHEMBL28112029 0.68 TP53 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850993-B1 Process for the preparation of blends of fluoropolymers, polyarylenesulphides and oxidized polyarylenesulphides TICONA GMBH (DE) 2003-05-02 EP claimed
US-6025440-A Mixture of fluoropolymers, oxidized polyarylene sulfides and polyarylene, sulfides HOECHST AKTIENGESELLSCHAFT (DE) 2000-02-15 US claimed
WO-2024151811-A1 PERSONALIZED CANCER VACCINES MODERNATX, INC. (US) 2024-07-18 WO disclosed
US-20240238210-A1 POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR THE TREATMENT OF CYSTIC FIBROSIS ARES CAPITAL CORPORATION, AS AGENT 2024-07-18 US disclosed
US-20240216529-A1 EXTRACELLULAR VESICLES WITH TARGETING MOIETY BIORCHESTRA CO., LTD. (KR) 2024-07-04 US disclosed
US-20240209035-A1 POLYNUCLEOTIDES CAPABLE OF ENHANCED PROTEIN EXPRESSION AND USES THEREOF BIORCHESTRA CO., LTD. (KR) 2024-06-27 US disclosed
WO-2024127317-A1 TREATING MITOCHONDRIAL DYSFUNCTION WITH MIRNA-485 INHIBITOR BIORCHESTRA CO., LTD. (KR) 2024-06-20 WO disclosed
EP-4376953-A1 PEPTIDE LIGANDS FOR CNS AND OCULAR DELIVERY OF RNAI COMPOUNDS Alnylam Pharmaceuticals, Inc. (US) 2024-06-05 EP disclosed
US-20240175020-A1 COMPOSITIONS OF MODIFIED TREMS AND USES THEREOF FLAGSHIP PIONEERING INNOVATIONS VI, LLC 2024-05-30 US disclosed
US-20240173348-A1 MICELLAR NANOPARTICLES AND USES THEREOF BIORCHESTRA CO., LTD. (KR) 2024-05-30 US disclosed
US-20240131048-A1 MICELLAR NANOPARTICLES AND USES THEREOF BIORCHESTRA CO., LTD. (KR) 2024-04-25 US disclosed
US-5786397-A Foamable molding compositions HOECHST AKTINEGESELLSCHAFT (DE) 1998-07-28 US disclosed
US-5760147-A Polyamide foams and process for their production HOECHST AKTIENGESELLSCHAFT (DE) 1998-06-02 US disclosed
US-5708041-A ENGINEERING THERMOPLASTICS, BLEND WITH POLYSULFOXIDES WHICH DECOMPOSE TO GASES CAUSING EXPANSION HOECHST AKTIENGESELLSCHAFT (DE) 1998-01-13 US disclosed
EP-0795025-A1 ENANTIOSELECTIVE PREPARATION OF PHARMACEUTICALLY ACTIVE SULFOXIDES BY BIOREDUCTION Astra Aktiebolag (SE) 1997-09-17 EP disclosed
US-5252764-A Reacting a gold halogenide dialkyl sulfide complex with mercaptan DEGUSSA AKTIENGESELLSCHAFT (DE) 1993-10-12 US disclosed
US-5247090-A Tricyclic [6,6,5]-fused oxazolidinone antibacterial agents THE UPJOHN COMPANY (US) 1993-09-21 US disclosed
US-5144004-A Heat resistance, selective degradation, reaction of halogen substituted sulfones and sulfoxides and alkali metal sulfides PHILLIPS PETROLEUM COMPANY (US) 1992-09-01 US disclosed
US-4902339-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-02-20 US disclosed
US-4801327-A Herbicidal sulfonamides E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-01-31 US disclosed